Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 4 098 2667 029 1615 153 3646 229 971--
Entreprise Value (EV)1 4 708 76012 054 7439 609 0549 862 5229 014 9838 549 620
P/E ratio 21,7x40,0x118x16,6x21,7x16,5x
Yield 3,47%3,98%5,44%4,52%4,76%4,76%
Capitalization / Revenue 2,31x3,35x1,57x1,95x1,79x1,77x
EV / Revenue 2,66x5,75x2,92x3,08x2,72x2,56x
EV / EBITDA 10,8x25,3x14,0x9,23x8,20x7,29x
Price to Book 2,03x1,36x1,09x1,20x1,19x1,18x
Nbr of stocks (in thousands) 790 7131 554 7801 557 8491 563 355--
Reference price (JPY) 5 1834 5213 3083 9853 7793 779
Last update 05/14/201805/14/201905/13/202005/11/202106/10/202106/10/2021
1 JPY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 1 770 5312 097 2003 291 2003 197 8123 309 9243 335 948
EBITDA1 437 460477 415684 0571 068 9401 098 8991 171 992
Operating profit (EBIT)1 241 789205 000100 400509 269504 822585 331
Operating Margin 13,7%9,77%3,05%15,9%15,3%17,5%
Pre-Tax Profit (EBT)1 217 20594 896-60 754366 235428 723504 152
Net income1 186 886109 10044 200376 005315 701385 116
Net margin 10,6%5,20%1,34%11,8%9,54%11,5%
EPS2 23911328,0241174229
Dividend per Share2 180180180180180180
Last update 05/14/201805/14/201905/13/202005/11/202106/10/202106/10/2021
1 JPY in Million
2 JPY
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 610 4945 025 5824 455 6903 632 5513 100 5392 635 176
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,40x10,5x6,51x3,40x2,82x2,25x
Free Cash Flow1 471 196-2 507 219961 871617 401861 006828 355
ROE (Net Profit / Equities) 9,60%3,00%0,90%7,60%6,76%8,71%
Shareholders' equity1 1 946 7293 636 6674 911 1114 947 4344 672 3034 421 389
ROA (Net Profit / Asset) 5,13%1,06%-0,46%2,85%3,53%3,95%
Assets1 3 640 51110 334 963-9 710 01813 209 9378 936 8659 758 425
Book Value Per Share2 2 5573 3193 0323 3093 1773 216
Cash Flow per Share2 490397403599568547
Capex1 67 00577 677127 082111 206186 370184 245
Capex / Sales 3,78%3,70%3,86%3,48%5,63%5,52%
Last update 05/14/201805/14/201905/13/202005/11/202106/10/202106/10/2021
1 JPY in Million
2 JPY
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (JPY)
5 914 444 262 023
Capitalization (USD)
53 877 389 065
Net sales (JPY)
3 291 200 000 000
Net sales (USD)
29 989 414 400
Number of employees
47 495
Sales / Employee (JPY)
69 295 715
Sales / Employee (USD)
631 423
Free-Float
99,1%
Free-Float capitalization (JPY)
5 859 451 301 292
Free-Float capitalization (USD)
53 376 432 930
Avg. Exchange 20 sessions (JPY)
21 006 527 587
Avg. Exchange 20 sessions (USD)
191 411 479
Average Daily Capital Traded
0,4%
EPS & Dividend